ClinConnect ClinConnect Logo
Search / Trial NCT06795711

Validation and Optimisation of Ultrasound Diagnosis of Adenomyosis

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 21, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Adenomyosis Gynaecology Ultrasound

ClinConnect Summary

This clinical trial is looking at how to improve the use of ultrasound for diagnosing a condition called adenomyosis, which affects the uterus. The researchers want to understand what normal measurements of the uterus should be and how often women with certain uterine problems experience repeated miscarriages. If you're a woman between the ages of 18 and 60 and are willing to provide informed consent, you may be eligible to participate in this study. However, if you've had a hysterectomy (surgery to remove the uterus), are still a virgin, have certain types of cancer, or have given birth or been pregnant in the last six months, you won't be able to take part.

Participants in this trial can expect to undergo a transvaginal ultrasound, which is a special type of ultrasound that helps doctors get a better look at the uterus. This study is currently recruiting participants, and it's important to know that your involvement could help improve how doctors diagnose and treat conditions like adenomyosis in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • age between 18 and 60;
  • obtaining informed consent
  • Exclusion Criteria:
  • Hysterectomised patients;
  • Virgo patients (hymenal integrity);
  • Patients reporting intolerance to transvaginal ultrasound;
  • Gynaecological oncology;
  • Recent pregnancy or childbirth (within 6 months);
  • Menopausal patients

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Diego Raimondo, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported